RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Eye drop battle: which protects vision better during cancer therapy?
Disease control Recruiting nowThis study aims to find the best way to protect patients' eyesight while they receive a targeted drug for recurrent ovarian cancer. It will compare two different types of preventive eye drops (steroid vs. vasoconstrictor) in 100 women to see which one better reduces vision-relate…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Ancient herb joins fight against tough ovarian cancer
Disease control Recruiting nowThis study is testing whether adding Ashwagandha, an herbal supplement, to a standard chemotherapy drug (DOXIL) can help control ovarian cancer that has returned after initial treatment. The first part of the study will find the safest dose of Ashwagandha to combine with chemo. T…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sham Sunder Kakar • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis study is testing a new drug called ubamatamab, given alone or with another drug (cemiplimab), for people with recurrent ovarian, fallopian tube, peritoneal, or endometrial cancers. The main goals are to find a safe and effective dose and to see if the treatment can shrink tu…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC